• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-221 通过靶向 PTEN 促进皮肤鳞状细胞癌的进展。

miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN.

机构信息

Department of Burn and Plastic Surgery, The First People's Hospital of Nantong, Nantong, 226001 China.

Department of Clinical Laboratory, The First People's Hospital of Nantong, Nantong, 226001 China.

出版信息

Cell Mol Biol Lett. 2019 Mar 8;24:9. doi: 10.1186/s11658-018-0131-z. eCollection 2019.

DOI:10.1186/s11658-018-0131-z
PMID:30891072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407258/
Abstract

BACKGROUND

Cutaneous squamous cell carcinoma (CSCC) is a common type of skin malignancy. MicroRNA-221 (miRNA-221) is a critical non-coding RNA in tumor initiation and progression. However, the molecular mechanisms of miRNA-221 in the development of CSCC remain unknown. This study investigated the expression of miRNA-221 in CSCC and its potential tumor biological functions.

METHODS

MTT assay, colony assay, PCR, and Western blot were adopted.

RESULTS

In this study, miRNA-221 expression was significantly higher in CSCC tissues and cell lines than in normal tissues and cells ( < 0.05). Further functional experiments indicated that miRNA-221 knockdown inhibited the proliferation and cell cycle, while upregulation of miRNA-221 presented the opposite role. The dual reporter gene assays indicated that PTEN is a direct target gene of miRNA-221. PTEN protein or mRNA levels were decreased after the cells were transfected with miR-221 mimics.

CONCLUSIONS

Taken together, the obtained results indicated that miR-221 plays an oncogenic function in CSCC by targeting PTEN and further suggest that miR-221 may be a potential target for CSCC diagnosis and treatment.

摘要

背景

皮肤鳞状细胞癌(CSCC)是一种常见的皮肤恶性肿瘤。微小 RNA-221(miRNA-221)是肿瘤起始和进展过程中关键的非编码 RNA。然而,miRNA-221 在 CSCC 发展中的分子机制尚不清楚。本研究旨在探讨 miRNA-221 在 CSCC 中的表达及其潜在的肿瘤生物学功能。

方法

采用 MTT 检测、集落形成实验、PCR 和 Western blot 检测。

结果

本研究表明,CSCC 组织和细胞系中的 miRNA-221 表达明显高于正常组织和细胞(<0.05)。进一步的功能实验表明,miRNA-221 下调抑制了细胞的增殖和细胞周期,而上调 miRNA-221 则呈现相反的作用。双荧光素酶报告基因实验表明,PTEN 是 miRNA-221 的直接靶基因。转染 miR-221 模拟物后,PTEN 蛋白或 mRNA 水平降低。

结论

综上所述,研究结果表明,miRNA-221 通过靶向 PTEN 在 CSCC 中发挥致癌作用,进一步提示 miR-221 可能是 CSCC 诊断和治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/5f9260c8612d/11658_2018_131_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/1cda209f3707/11658_2018_131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/08841320d770/11658_2018_131_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/11f485a51daf/11658_2018_131_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/44465e332dab/11658_2018_131_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/5f9260c8612d/11658_2018_131_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/1cda209f3707/11658_2018_131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/08841320d770/11658_2018_131_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/11f485a51daf/11658_2018_131_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/44465e332dab/11658_2018_131_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84f/6407258/5f9260c8612d/11658_2018_131_Fig5_HTML.jpg

相似文献

1
miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN.miRNA-221 通过靶向 PTEN 促进皮肤鳞状细胞癌的进展。
Cell Mol Biol Lett. 2019 Mar 8;24:9. doi: 10.1186/s11658-018-0131-z. eCollection 2019.
2
MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.微小 RNA-142-5p 通过抑制 PTEN 诱导皮肤鳞状细胞癌的癌症干细胞样特性。
J Cell Biochem. 2018 Feb;119(2):2179-2188. doi: 10.1002/jcb.26379. Epub 2017 Oct 20.
3
miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.miR-497 通过 FAM114A2 促进皮肤鳞状细胞癌的进展。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7348-7355. doi: 10.26355/eurrev_201811_16272.
4
Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.环状 RNA circ-LARP1B 通过靶向 microRNA-515-5p/TPX2 微管成核因子轴促进皮肤鳞状细胞癌的进展。
Bioengineered. 2022 Jan;13(1):1209-1223. doi: 10.1080/21655979.2021.2019172.
5
MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.微小 RNA-125b 下调基质金属蛋白酶 13,抑制皮肤鳞状细胞癌细胞增殖、迁移和侵袭。
J Biol Chem. 2012 Aug 24;287(35):29899-908. doi: 10.1074/jbc.M112.391243. Epub 2012 Jul 10.
6
MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.微小RNA-130b通过抑制食管鳞状细胞癌细胞中PTEN的表达发挥致癌作用。
BMC Cancer. 2015 Jan 31;15:29. doi: 10.1186/s12885-015-1031-5.
7
CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.环状 RNA circ_0067772 通过调控 miR-1238-3p/FOXG1 轴促进皮肤鳞状细胞癌的恶性进展。
Genes Genomics. 2021 May;43(5):491-501. doi: 10.1007/s13258-021-01074-3. Epub 2021 Mar 11.
8
MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.微小 RNA-125b 通过靶向 STAT3 通路在皮肤鳞状细胞癌中发挥抗肿瘤作用。
Cell Mol Biol Lett. 2020 Mar 5;25:12. doi: 10.1186/s11658-020-00207-y. eCollection 2020.
9
MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.微小RNA-20a通过直接靶向LIMK1抑制皮肤鳞状细胞癌的转移和增殖。
Cancer Biol Ther. 2014 Oct;15(10):1340-9. doi: 10.4161/cbt.29821. Epub 2014 Jul 14.
10
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.miRNA-214 通过 VEGFA 和 Bcl-2 预防皮肤鳞状细胞癌的特征。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980098. doi: 10.1177/1533033820980098.

引用本文的文献

1
miRNA: The Next Frontier in Dermatology Research and Therapeutics.微小RNA:皮肤病学研究与治疗的新前沿
Indian J Dermatol. 2024 Nov-Dec;69(6):486. doi: 10.4103/ijd.ijd_568_23. Epub 2024 Oct 29.
2
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.皮肤鳞状细胞癌的突变和微环境格局:综述
Cancers (Basel). 2024 Aug 21;16(16):2904. doi: 10.3390/cancers16162904.
3
Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.微小 RNA 在角质细胞癌中的失调:临床证据、功能影响和未来方向。

本文引用的文献

1
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.卵巢癌中异常甲基化调控的新型 miRNA 基因参与转移。
Gene. 2018 Jul 1;662:28-36. doi: 10.1016/j.gene.2018.04.005. Epub 2018 Apr 6.
2
MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.miR-326 和 miR-200c:小儿急性淋巴细胞白血病诊断和预后的两个新生物标志物。
J Cell Biochem. 2018 Jul;119(7):6024-6032. doi: 10.1002/jcb.26800. Epub 2018 Apr 6.
3
Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based study.
Int J Mol Sci. 2024 Aug 3;25(15):8493. doi: 10.3390/ijms25158493.
4
Selective targeting of α7 nicotinic acetylcholine receptor by synthetic peptide mimicking loop I of human SLURP-1 provides efficient and prolonged therapy of epidermoid carcinoma .通过模拟人SLURP-1环I的合成肽对α7烟碱型乙酰胆碱受体进行选择性靶向,可有效且持久地治疗表皮样癌。
Front Cell Dev Biol. 2023 Oct 3;11:1256716. doi: 10.3389/fcell.2023.1256716. eCollection 2023.
5
Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.Hsa_circ_0001535 通过海绵吸附 miR-593-3p,上调 PTEN 表达,抑制卵巢癌细胞的增殖和迁移。
Clin Transl Oncol. 2023 Oct;25(10):2901-2910. doi: 10.1007/s12094-023-03152-2. Epub 2023 Mar 31.
6
Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review.免疫功能正常和免疫抑制宿主皮肤鳞状细胞癌的分子改变——一项系统综述
Cancers (Basel). 2023 Mar 17;15(6):1832. doi: 10.3390/cancers15061832.
7
The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region.miRNA-221 和 miRNA-34a 在头颈部非黑素瘤皮肤癌中的作用。
Genes (Basel). 2023 Feb 16;14(2):503. doi: 10.3390/genes14020503.
8
The clinicopathological and microrna expression signature associated with lymphovascular invasion in squamous cell carcinoma: A basic descriptive study.与鳞状细胞癌中淋巴管侵犯相关的临床病理及微小RNA表达特征:一项基础描述性研究。
Health Sci Rep. 2022 Nov 25;5(6):e958. doi: 10.1002/hsr2.958. eCollection 2022 Nov.
9
Alkannin exerts antitumor properties in cutaneous squamous cell carcinoma by inducing apoptosis and shifting the M1/M2 polarization of tumor-associated macrophages by upregulating PTEN.白花丹素通过上调 PTEN 诱导细胞凋亡并改变肿瘤相关巨噬细胞的 M1/M2 极化状态从而发挥对皮肤鳞状细胞癌的抗肿瘤作用。
Kaohsiung J Med Sci. 2023 Jan;39(1):70-79. doi: 10.1002/kjm2.12617. Epub 2022 Nov 11.
10
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.circ_0025033 通过调控 hsa-miR-370-3p/SLC1A5 轴促进卵巢癌细胞的发展。
Cell Mol Biol Lett. 2022 Oct 22;27(1):94. doi: 10.1186/s11658-022-00364-2.
血清 miR-658 通过激活 PAX3-MET 通路诱导胃癌转移:一项基于人群的研究。
Cancer Biomark. 2018;22(1):111-118. doi: 10.3233/CBM-171045.
4
MiRNA-155 and colorectal cancer, the role of real time PCR in laboratory diagnosis.微小RNA-155与结直肠癌,实时聚合酶链反应在实验室诊断中的作用
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1521-1524. doi: 10.26355/eurrev_201803_14553.
5
Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma.皮肤鳞状细胞癌的新型治疗靶点
Front Oncol. 2018 Mar 23;8:79. doi: 10.3389/fonc.2018.00079. eCollection 2018.
6
Inhibiting TRK Proteins in Clinical Cancer Therapy.在临床癌症治疗中抑制TRK蛋白
Cancers (Basel). 2018 Apr 4;10(4):105. doi: 10.3390/cancers10040105.
7
20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.20(S)-原人参二醇通过抑制 PI3K/AKT/mTOR 信号通路诱导 MCF-7 乳腺癌细胞凋亡。
Int J Mol Sci. 2018 Apr 2;19(4):1053. doi: 10.3390/ijms19041053.
8
Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.皮肤鳞状细胞癌:发病率、危险因素、诊断和分期。
J Am Acad Dermatol. 2018 Feb;78(2):237-247. doi: 10.1016/j.jaad.2017.08.059.
9
Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.miR-221-3p的下调及其靶基因PARP1的上调是三阴性乳腺癌患者的预后生物标志物,且与预后不良相关。
Oncotarget. 2017 Oct 6;8(65):108712-108725. doi: 10.18632/oncotarget.21561. eCollection 2017 Dec 12.
10
MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.微小RNA-34a直接靶向高迁移率族蛋白盒1,并抑制皮肤鳞状细胞癌中的癌细胞增殖、迁移和侵袭。
Exp Ther Med. 2017 Dec;14(6):5611-5618. doi: 10.3892/etm.2017.5245. Epub 2017 Oct 2.